COMMUNIQUÉS West-GlobeNewswire

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC
05/09/2024
TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its executive management team will [...]
Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
05/09/2024
As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) MARLBOROUGH, Mass., BERLIN, Germany, and YOKNEAM [...]
Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting
05/09/2024
ATLANTA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, [...]
Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission
05/09/2024
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Better Choice Company Provides Shareholder Update on Balance Sheet
05/09/2024
Pro Forma Adjusted Net Tangible Book Value Per Share (NTBVPS) Increases 6% to $4.07 per share Pro Forma Adjusted Net Current Asset Value Per Share (NCAVPS) Increases 16% to $3.94 per share TAMPA, Fla., Sept. 05, 2024 ( [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2024
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Sotera Health Announces Secondary Offering of Common Stock
04/09/2024
CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $ [...]
Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences
04/09/2024
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117 [...]
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
04/09/2024
Châtillon, France, September 4, 2024 DBV Technologies to Participate in the H.C. Wainwright 26 th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]
DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment
04/09/2024
Châtillon, France, 4 septembre, 2024 (22:30 CET) DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/09/2024
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 04 sept. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
04/09/2024
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2024
WALTHAM, Mass. and DUBLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to [...]
Streamline Health® To Report Fiscal Second Quarter 2024 Financial Performance
04/09/2024
ATLANTA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM) , a leading provider of solutions that enable healthcare providers to proactively address [...]
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
04/09/2024
TORONTO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]
Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference
04/09/2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing [...]
Shuttle Pharma Provides Second Quarter 2024 Corporate Update
04/09/2024
GAITHERSBURG, Md., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
04/09/2024
Dr. Margaret A. Liu, global expert in vaccines, gene therapy, and cancer immunotherapy; chief executive officer of PAX Therapeutics and member of several boards Ms. Anat Naschitz, proven life science investor and [...]
NANOBIOTIX annonce deux ajouts clés auprès de son conseil de surveillance dans la perspective d’une croissance durable et à long terme de la société
04/09/2024
Dr Margaret A. Liu, experte mondiale en vaccins, thérapie génique et immunothérapie contre le cancer, Chief Executive Officer chez PAX Therapeutics et membre de plusieurs conseils d’administration Anat Naschitz, [...]

Pages